Stocktoria
Aligos Therapeutics, Inc. ALGS
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-10-16
Aligos Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 100,450 | $746,344 |
| CITADEL ADVISORS LLC | 54,311 | $403,531 |
| TWO SIGMA INVESTMENTS, LP | 23,093 | $171,581 |
| D. E. Shaw & Co., Inc. | 10,978 | $81,567 |
Source: SEC EDGAR filings · CIK 0001799448 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.